v3.24.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
Common Stock
ADS
Common Stock
Treasury Stock
Additional Paid In Capital
Accumulated Deficit
ADS
Total
Balance at beginning of year at Dec. 31, 2020       $ 100 $ (6,607,397)   $ (6,607,297)
Balance at beginning of year (in shares) at Dec. 31, 2020 20,025 20,025          
Net loss         (21,462,588)   (21,462,588)
Conversion of "2020 Notes" into ordinary shares       1,213,313     1,213,313
Conversion of "2020 Notes" into ordinary shares (in shares) 433 433          
Issuance of ADS and Pre-Funded Warrants, net       17,000,000     17,000,000
Issuance of ADS and Pre-Funded Warrants, net (in shares) 28,508 28,508          
Costs associated with sale of equity securities       1,897,126     1,897,126
Merger recapitalization of Cellect     $ (2,932,000) 2,932,000      
Merger recapitalization of Cellect (in shares) 6,947 6,947          
Reclassification of warrant liability upon issuance of Exchange warrant       12,410,730     12,410,730
Balance at end of year at Dec. 31, 2021     (2,932,000) 31,659,017 (28,069,985)   $ 657,032
Balance at ending of year (in shares) at Dec. 31, 2021 55,913 55,913       55,913 55,913
Net loss         (1,682,802)   $ (1,682,802)
Cashless exercise of warrants (in shares)   1       1  
Reclassification of warrant liability upon issuance of Exchange warrant       296,362     296,362
Balance at end of year at Mar. 31, 2022     (2,932,000) 31,955,379 (29,752,787)   (729,408)
Balance at ending of year (in shares) at Mar. 31, 2022   55,914       55,914  
Balance at beginning of year at Dec. 31, 2021     (2,932,000) 31,659,017 (28,069,985)   $ 657,032
Balance at beginning of year (in shares) at Dec. 31, 2021 55,913 55,913       55,913 55,913
Net loss             $ (7,380,536)
Balance at end of year at Sep. 30, 2022     (2,932,000) 47,615,475 (35,515,787)   9,167,688
Balance at ending of year (in shares) at Sep. 30, 2022   403,887       403,887  
Balance at beginning of year at Dec. 31, 2021     (2,932,000) 31,659,017 (28,069,985)   $ 657,032
Balance at beginning of year (in shares) at Dec. 31, 2021 55,913 55,913       55,913 55,913
Net loss         (9,381,496)   $ (9,381,496)
Stock based compensation       764,007     764,007
Issuance of ADS and Pre-Funded Warrants, net       14,877,332     14,877,332
Issuance of ADS and Pre-Funded Warrants, net (in shares) 280,000 280,000          
Cashless exercise of warrants (in shares) 64,292 64,292          
Settlement of accrued expenses       193,537     193,537
Settlement of accrued expenses (in shares) 3,682 3,682          
Reclassification of warrant liability upon issuance of Exchange warrant       296,362     296,362
Deemed dividend on warrant modification       65,266 (65,266)    
Balance at end of year at Dec. 31, 2022     (2,932,000) 47,855,521 (37,516,747)   $ 7,406,774
Balance at ending of year (in shares) at Dec. 31, 2022 403,887 403,887       403,887 403,887
Balance at beginning of year at Mar. 31, 2022     (2,932,000) 31,955,379 (29,752,787)   $ (729,408)
Balance at beginning of year (in shares) at Mar. 31, 2022   55,914       55,914  
Net loss         (2,668,167)   (2,668,167)
Stock based compensation       229,441     229,441
Cashless exercise of warrants (in shares)   28,508       28,508  
Balance at end of year at Jun. 30, 2022     (2,932,000) 32,184,820 (32,420,954)   (3,168,134)
Balance at ending of year (in shares) at Jun. 30, 2022   84,422       84,422  
Net loss         (3,029,567)   (3,029,567)
Stock based compensation       267,283     267,283
Issuance of ADS and Pre-Funded Warrants, net       14,904,569     14,904,569
Issuance of ADS and Pre-Funded Warrants, net (in shares)   280,000       280,000  
Cashless exercise of warrants (in shares)   35,783       35,783  
Settlement of accrued expenses       193,537     193,537
Settlement of accrued expenses (in shares)   3,682       3,682  
Deemed dividend on warrant modification       65,266 (65,266)    
Balance at end of year at Sep. 30, 2022     (2,932,000) 47,615,475 (35,515,787)   9,167,688
Balance at ending of year (in shares) at Sep. 30, 2022   403,887       403,887  
Balance at beginning of year at Dec. 31, 2022     (2,932,000) 47,855,521 (37,516,747)   $ 7,406,774
Balance at beginning of year (in shares) at Dec. 31, 2022 403,887 403,887       403,887 403,887
Net loss         (2,603,069)   $ (2,603,069)
Stock based compensation       261,472     261,472
Issuance of ADS and Pre-Funded Warrants, net       5,849,266     5,849,266
Issuance of ADS and Pre-Funded Warrants, net (in shares)   583,333       583,333  
Balance at end of year at Mar. 31, 2023     (2,932,000) 53,966,259 (40,119,816)   10,914,443
Balance at ending of year (in shares) at Mar. 31, 2023   987,220       987,220  
Balance at beginning of year at Dec. 31, 2022     (2,932,000) 47,855,521 (37,516,747)   $ 7,406,774
Balance at beginning of year (in shares) at Dec. 31, 2022 403,887 403,887       403,887 403,887
Net loss             $ (6,636,695)
Balance at end of year at Sep. 30, 2023     (2,932,000) 54,499,138 (44,153,442)   $ 7,413,696
Balance at ending of year (in shares) at Sep. 30, 2023   987,220       987,220 987,220
Balance at beginning of year at Mar. 31, 2023     (2,932,000) 53,966,259 (40,119,816)   $ 10,914,443
Balance at beginning of year (in shares) at Mar. 31, 2023   987,220       987,220  
Net loss         (2,106,947)   (2,106,947)
Stock based compensation       264,376     264,376
Balance at end of year at Jun. 30, 2023     (2,932,000) 54,230,635 (42,226,763)   9,071,872
Balance at ending of year (in shares) at Jun. 30, 2023   987,220       987,220  
Net loss         (1,926,679)   (1,926,679)
Stock based compensation       268,503     268,503
Balance at end of year at Sep. 30, 2023     $ (2,932,000) $ 54,499,138 $ (44,153,442)   $ 7,413,696
Balance at ending of year (in shares) at Sep. 30, 2023   987,220       987,220 987,220